The DOI matches its Crossref record.
EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1
Abstract
BACKGROUND: Triple drug treatment consisting of mycophenolate mofetil (MMF), in a standard dose of 2 g daily, combined with cyclosporine (CsA) and prednisone, has become the standard immunosuppressive regimen after kidney transplantation in many centers. The need for therapeutic drug monitoring of mycophenolic acid (MPA) has not yet been established. Several drug interactions with MMF are known. We investigated the influence of CsA withdrawal on MPA trough levels in renal transplant patients. METHODS: Fifty-two patients were treated with 1 g of MMF twice daily, and prednisone and CsA targeted between 125 and 175 ng/ml for 6 months after transplantation. At 6 months after transplantation, 19 patients were randomized for continuation of triple therapy (group A), 19 patients discontinued CsA (group B), and 14 patients discontinued prednisone (group C). We compared 12-hr fasted MPA trough levels at 6 and 9 months after transplantation within and between these groups. RESULTS: MPA trough levels during treatment with CsA, MMF, and prednisone were significantly lower than those during treatment with MMF and prednisone only (group B); median levels were 1.87 mg/L (range: 0.56-5.27) vs. 3.16 mg/L (range: 0.32-7.78), respectively (P=0.002). MPA trough levels in groups A and C did not change between 6 and 9 months after transplantation; group A median levels were 1.87 (range: 0.31-4.32) vs. 1.53 mg/L (range: 0.36-3.70), and group C median levels were 1.62 (range: 0.69-10.34) vs. 1.79 mg/L (range: 0.54-6.00), respectively. At 9 months after transplantation, patients in whom CsA was discontinued had higher MPA trough levels as compared with patients who continued the use of triple therapy (P=0.001) or patients in whom steroids were withdrawn (P=0.014). CONCLUSION: A significant increase of MPA trough levels was found after discontinuation of CsA (6 months after transplantation), resulting in almost a doubling of MPA trough levels at 9 months after transplantation. This resulted in increased MPA levels in patients without CsA as compared to MPA levels in patients continuing triple therapy or discontinuing prednisone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients
Staatz, C. E., & Tett, S. E. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746010-00002 · Cited by 602
Plosker, G. L., & Foster, R. H. (2000) · Drugs · doi:10.2165/00003495-200059020-00021 · Cited by 343
Adverse Gastrointestinal Effects of Mycophenolate Mofetil: Aetiology, Incidence and Management
Behrend, M. (2001) · Drug Safety · doi:10.2165/00002018-200124090-00002 · Cited by 322
Shaw, L. M., Holt, D. W., Oellerich, M., Meiser, B., & van Gelder, T. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200108000-00001 · Cited by 261
Self-citationSteroid avoidance or withdrawal for kidney transplant recipients
Haller, M. C., Royuela, A., Nagler, E. V., Pascual, J., & Webster, A. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005632.pub3 · Cited by 258
Metadata
- Authors
- Smak Gregoor, P. J. H., de S??vaux, R. G. L., Hen??, R. J., Hesse, C. J., Hilbrands, L. B., Vos, P., van Gelder, T., Hoitsma, A. J., & Weimar, W.
- Venue
- Transplantation
- Published
- 1999-11
- Volume
- 68
- Issue
- 10
- Pages
- 1603-1606
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2067353313
- Cited by
- 174
- References
- 0
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1. https://app.cochat.ai/papers/10.1097/00007890-199911270-00028
- The paper
- Smak Gregoor, P. J. H., de S??vaux, R. G. L., Hen??, R. J., Hesse, C. J., Hilbrands, L. B., Vos, P., van Gelder, T., Hoitsma, A. J., & Weimar, W. (1999). EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1. Transplantation. https://doi.org/10.1097/00007890-199911270-00028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.